Stay updated on Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a newer version of the page. This metadata change does not modify study data or user-facing content beyond the version label.SummaryDifference0.0%

- Check19 days agoChange DetectedA new site revision (v3.6.2) was added to the record history and the previous revision (v3.6.0) was removed, reflecting a platform update in the page history.SummaryDifference0.0%

- Check34 days agoChange DetectedNo longer looking for participants indicates recruitment has ended. The history adds Revision: v3.6.0 and removes Revision: v3.5.5 from the record.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page history now shows Revision: v3.5.5 as the latest version, replacing the previous v3.5.4.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page footer now shows Revision: v3.5.4, indicating the site was updated to a newer release.SummaryDifference0.0%

- Check77 days agoChange DetectedA new revision entry, v3.5.3, has been added to the history and the previous entry, v3.5.2, has been removed, updating the record of the page revisions.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.